The Prospecive OBSERVational Munich Interventional MITRAl-Valve Registry (OBSERV-MITRA)

German Heart Center Munich

Status: Enrolling

Conditions: Mitral Valve Regurgitation; Mitral Valve Stenosis; Tricuspid Valve Regurgitation

Treatments: Device: edge-to-edge valve repair

Study type: Observational

Funder types: Other

Identifiers

NCT04577248

GE DHM-AN-EHK-2020/09

Details and patient eligibility

About

Prospective, single-center observational registry including all consecutive patients treated with transcatheter mitral or tricuspid valve therapy at the Deutsches Herzzentrum München, Germany.

Full description

Long-term mortality after transcatheter mitral or tricuspid valve therapy

Enrollment: 5,000 estimated patients

Sex: All

Ages: 18 to 110 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Age above 18 years and consentable
• Mitral Valve Regurgitation, Mitral Valve Stenosis, Tricuspid Valve Regurgitation, Tricuspid Stenosis
• Transcatheter mitral or tricuspid valve therapy considered best option by heart-team decision
• Written informed consent

Exclusion criteria

• Patient's inability to fully cooperate with the protocol